fda ghk-cu immunogenicity Status and Compounding Update 2026: What… GHK-CU – NU BIOGEN
Description
One of the antigens identified, metE, conferred significant protection against MTB in mice when delivered as a protein/adjuvant vaccine candidate, suggesting its potential for inclusion in the next-generation of TB vaccines
10.1007/s10295-014-1562-9 [DOI] [PubMed] [Google Scholar] Xie, Y
A healthcare professional should administer the injection
However, supplementation may be necessary in certain situations
W.HernandezK
Why KLOW Works Better Together Than Alone Each peptide in KLOW is effective independently, but their synergy is where the formulation truly excels
